1. Home
  2. NVCR vs HUT Comparison

NVCR vs HUT Comparison

Compare NVCR & HUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • HUT
  • Stock Information
  • Founded
  • NVCR 2000
  • HUT 2011
  • Country
  • NVCR Switzerland
  • HUT United States
  • Employees
  • NVCR N/A
  • HUT N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • HUT Finance: Consumer Services
  • Sector
  • NVCR Health Care
  • HUT Finance
  • Exchange
  • NVCR Nasdaq
  • HUT Nasdaq
  • Market Cap
  • NVCR 1.9B
  • HUT 1.6B
  • IPO Year
  • NVCR 2015
  • HUT N/A
  • Fundamental
  • Price
  • NVCR $16.69
  • HUT $16.70
  • Analyst Decision
  • NVCR Buy
  • HUT Strong Buy
  • Analyst Count
  • NVCR 6
  • HUT 14
  • Target Price
  • NVCR $32.83
  • HUT $26.64
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • HUT 6.3M
  • Earning Date
  • NVCR 07-24-2025
  • HUT 08-12-2025
  • Dividend Yield
  • NVCR N/A
  • HUT N/A
  • EPS Growth
  • NVCR N/A
  • HUT N/A
  • EPS
  • NVCR N/A
  • HUT N/A
  • Revenue
  • NVCR $621,711,000.00
  • HUT $132,459,000.00
  • Revenue This Year
  • NVCR $5.56
  • HUT $74.79
  • Revenue Next Year
  • NVCR $9.19
  • HUT $116.78
  • P/E Ratio
  • NVCR N/A
  • HUT N/A
  • Revenue Growth
  • NVCR 18.27
  • HUT 0.24
  • 52 Week Low
  • NVCR $14.17
  • HUT $8.73
  • 52 Week High
  • NVCR $34.13
  • HUT $31.95
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.44
  • HUT 50.50
  • Support Level
  • NVCR $17.20
  • HUT $17.35
  • Resistance Level
  • NVCR $18.02
  • HUT $18.60
  • Average True Range (ATR)
  • NVCR 1.04
  • HUT 1.07
  • MACD
  • NVCR -0.09
  • HUT -0.19
  • Stochastic Oscillator
  • NVCR 15.51
  • HUT 39.39

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

Share on Social Networks: